Evidence map›Paper›PMID 31247918›Full record

ArticleInternational journal of molecular sciences2019

Isolated Compounds from

Zuha Imtiyaz, Yi-Fang Wang, Yi-Tzu Lin, Hui-Kang Liu, Mei-Hsien Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Laricitrin 3-Rutinoside fromAntioxidants (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Review
  6. Preparation and Characterization of Calcium-IncorporatedEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  7. Compounds Isolated fromFrontiers in pharmacology · 2021
    Article
  8. Compounds isolated fromSaudi journal of biological sciences · 2020
    Article
  9. A Network Pharmacology-Based Study on the Anti-Lung Cancer Effect of Dipsaci Radix.Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Zuha ImtiyazClinical Drug Development of Herbal Medicine, Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 11031, Taiwan.
Yi-Fang WangGraduate Institute of Pharmacognosy, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan.
Yi-Tzu LinClinical Drug Development of Herbal Medicine, Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 11031, Taiwan.
Hui-Kang LiuClinical Drug Development of Herbal Medicine, Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 11031, Taiwan.
Mei-Hsien LeeClinical Drug Development of Herbal Medicine, Graduate Institute of Pharmacognosy, Taipei Medical University, Taipei 11031, Taiwan. lmh@tmu.edu.tw.ORCID 0000-0001-8592-9326
Taipei Medical University · TWNational Research Institute of Chinese Medicine · TWTaipei Medical University Hospital · TW

Funding

Ministry of Science and Technology NSC101-2320-B-038-014-MY3(2-3)
6 · The paper itself

Abstract

Bone metabolism is a homeostatic process, imbalance in which leads to the onset of diseases such as osteoporosis and osteopenia. Although several drugs are currently available to treat such conditions, they are associated with severe side effects and do not enhance bone formation. Thus, identifying alternative treatment strategies that focus on enhancing bone formation is essential. Herein, we explored the osteogenic potential of

Indexed as

BiomarkersCalcification, PhysiologicGene ExpressionMagnetic Resonance SpectroscopyMolecular StructureOsteoblastsOsteogenesisPhytochemicalsPlant ExtractsReceptors, EstrogenTracheophytaBiomarkersPhytochemicalsPlant ExtractsReceptors, Estrogen3,3′-di-O-methylellagic acid-4-O-α-l-arabinofuranosidealkaline phosphatasebone formationestrogen receptorsmineralizationosteoporosisTurpinia formosana

Identifiers

PMID31247918
PMCPMC6651545
OpenAlexW2955751285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.